Literature DB >> 27262570

Neuroendocrine carcinoma of the pancreas with similar genetic alterations to invasive ductal adenocarcinoma.

Tetsuo Kimura1, Hiroshi Miyamoto1, Akira Fukuya1, Shinji Kitamura1, Koichi Okamoto1, Masako Kimura1, Naoki Muguruma1, Tetsuya Ikemoto2, Mitsuo Shimada2, Akiko Yoneda3, Yoshimi Bando3, Makoto Takishita4, Tetsuji Takayama5.   

Abstract

Neuroendocrine carcinoma (NEC) of the pancreas is very rare, and its origin is not fully elucidated. Here, we present a case of a small-size NEC of the pancreas that is genetically similar to invasive ductal adenocarcinoma (IDA). A 65-year-old man was referred to our hospital due to obstructive jaundice and found to have a 12-mm solid tumor in the pancreas head. The tumor exhibited low vascularity on enhanced computed tomography, and endoscopic retrograde pancreatographic imaging revealed an irregular obstruction in a branch duct of the pancreas. The patient was thereby diagnosed with a pancreatic ductal cancer, and stomach-preserving pancreaticoduodenectomy with regional lymph node resection was performed. Histochemical analysis of the resected tumor showed that the neoplastic cells with scanty cytoplasm and hyperchromatic nuclei strongly expressed chromogranin A and synaptophysin. The Ki-67 index was 40 % in the most proliferative tumor regions, and the tumor was diagnosed as a NEC of the pancreas. However, in the analysis of genetic alterations of the tumor tissue, the neoplastic cells showed altered KRAS, TP53, and SMAD4/DPC4, suggesting that the NEC in our case is genetically related to IDA. Our data suggest that poorly differentiated IDAs may transform into NECs.

Entities:  

Keywords:  KRAS; Neuroendocrine carcinoma; Pancreatic cancer; SMAD4; p53

Mesh:

Substances:

Year:  2016        PMID: 27262570     DOI: 10.1007/s12328-016-0655-6

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  13 in total

1.  Islet cell tumor of the pancreas: biphasic CT versus MR imaging in tumor detection.

Authors:  T Ichikawa; M S Peterson; M P Federle; R L Baron; H Haradome; Y Kawamori; S Nawano; T Araki
Journal:  Radiology       Date:  2000-07       Impact factor: 11.105

Review 2.  Progression model for pancreatic cancer.

Authors:  R H Hruban; M Goggins; J Parsons; S E Kern
Journal:  Clin Cancer Res       Date:  2000-08       Impact factor: 12.531

3.  Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors.

Authors:  Shinichi Yachida; Efsevia Vakiani; Catherine M White; Yi Zhong; Tyler Saunders; Richard Morgan; Roeland F de Wilde; Anirban Maitra; Jessica Hicks; Angelo M Demarzo; Chanjuan Shi; Rajni Sharma; Daniel Laheru; Barish H Edil; Christopher L Wolfgang; Richard D Schulick; Ralph H Hruban; Laura H Tang; David S Klimstra; Christine A Iacobuzio-Donahue
Journal:  Am J Surg Pathol       Date:  2012-02       Impact factor: 6.394

4.  Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases.

Authors:  Olca Basturk; Laura Tang; Ralph H Hruban; Volkan Adsay; Zhaohai Yang; Alyssa M Krasinskas; Efsevia Vakiani; Stefano La Rosa; Kee-Taek Jang; Wendy L Frankel; Xiuli Liu; Lizhi Zhang; Thomas J Giordano; Andrew M Bellizzi; Jey-Hsin Chen; Chanjuan Shi; Peter Allen; Diane L Reidy; Christopher L Wolfgang; Burcu Saka; Neda Rezaee; Vikram Deshpande; David S Klimstra
Journal:  Am J Surg Pathol       Date:  2014-04       Impact factor: 6.394

5.  Small serotonin-producing neuroendocrine tumor of the pancreas associated with pancreatic duct obstruction.

Authors:  Satomi Kawamoto; Chanjuan Shi; Ralph H Hruban; Michael A Choti; Richard D Schulick; Elliot K Fishman; Stanley S Siegelman
Journal:  AJR Am J Roentgenol       Date:  2011-09       Impact factor: 3.959

6.  Small cell carcinoma of the pancreas and biliary tract.

Authors:  K Motojima; J Furui; M Terada; T Shiogama; N Kohara; T Tsunoda; R Tsuchiya
Journal:  J Surg Oncol       Date:  1990-11       Impact factor: 3.454

7.  Pancreatic duct stenosis secondary to small endocrine neoplasms: a manifestation of serotonin production?

Authors:  Chanjuan Shi; Stanley S Siegelman; Satomi Kawamoto; Christopher L Wolfgang; Richard D Schulick; Anirban Maitra; Ralph H Hruban
Journal:  Radiology       Date:  2010-08-16       Impact factor: 11.105

8.  Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study.

Authors:  H Sorbye; S Welin; S W Langer; L W Vestermark; N Holt; P Osterlund; S Dueland; E Hofsli; M G Guren; K Ohrling; E Birkemeyer; E Thiis-Evensen; M Biagini; H Gronbaek; L M Soveri; I H Olsen; B Federspiel; J Assmus; E T Janson; U Knigge
Journal:  Ann Oncol       Date:  2012-09-11       Impact factor: 32.976

9.  Cadherin 17 is frequently expressed by 'sclerosing variant' pancreatic neuroendocrine tumour.

Authors:  Adam Johnson; Jesse P Wright; Zhiguo Zhao; Tatsuki Komaya; Alexander Parikh; Nipun Merchant; Chanjuan Shi
Journal:  Histopathology       Date:  2014-10-28       Impact factor: 5.087

10.  Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas?

Authors:  Susumu Hijioka; Waki Hosoda; Nobumasa Mizuno; Kazuo Hara; Hiroshi Imaoka; Vikram Bhatia; Mohamed A Mekky; Masahiro Tajika; Tsutomu Tanaka; Makoto Ishihara; Tatsuji Yogi; Hideharu Tsutumi; Toshihisa Fujiyoshi; Takamitsu Sato; Nobuhiro Hieda; Tsukasa Yoshida; Nozomi Okuno; Yasuhiro Shimizu; Yasushi Yatabe; Yasumasa Niwa; Kenji Yamao
Journal:  J Gastroenterol       Date:  2014-08-21       Impact factor: 7.527

View more
  8 in total

1.  A gastric MANEC with an adenocarcinoma of fundic-gland type as exocrine component.

Authors:  Hussein Nassereddine; Nicolas Poté; Nathalie Théou-Anton; Gaële Lamoureux; Jean-François Fléjou; Anne Couvelard
Journal:  Virchows Arch       Date:  2017-06-26       Impact factor: 4.064

Review 2.  Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites.

Authors:  Silvia Uccella; Stefano La Rosa; Jasna Metovic; Deborah Marchiori; Jean-Yves Scoazec; Marco Volante; Ozgur Mete; Mauro Papotti
Journal:  Endocr Pathol       Date:  2021-01-12       Impact factor: 3.943

3.  A case of mixed adenoneuroendocrine carcinoma of the pancreas mimicking intraductal papillary mucinous carcinoma.

Authors:  Hideki Mori; Keiji Hanada; Tomoyuki Minami; Shigeki Yano; Motomitsu Fukuhara; Hirotsugu Maruyama; Akinori Shimizu; Naomichi Hirano; Fumiaki Hino; Hironobu Amano; Shuji Yonehara
Journal:  Clin J Gastroenterol       Date:  2018-02-13

Review 4.  Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future.

Authors:  Akihiro Ohmoto; Hirofumi Rokutan; Shinichi Yachida
Journal:  Int J Mol Sci       Date:  2017-01-13       Impact factor: 5.923

5.  Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.

Authors:  Chuangen Guo; Xiao Chen; Zhongqiu Wang; Wenbo Xiao; Qidong Wang; Ke Sun; Xiaoling Zhuge
Journal:  Oncotarget       Date:  2017-06-27

6.  Differentiating pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas by the "Duct-Road Sign": A preliminary magnetic resonance imaging study.

Authors:  Bo Xiao; Zhi-Qiong Jiang; Jin-Xiang Hu; Xiao-Ming Zhang; Hai-Bo Xu
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

7.  A pancreatic mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN) (NET and undifferentiated carcinoma of the pancreas with osteoclast-like giant cells) with metastatic neuroendocrine component to the liver.

Authors:  Guofeng Gao; Amir Qorbani; Chihong Heidi Zhou
Journal:  Autops Case Rep       Date:  2020-12-08

8.  Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.

Authors:  Shuai Ren; Xiao Chen; Zhonglan Wang; Rui Zhao; Jianhua Wang; Wenjing Cui; Zhongqiu Wang
Journal:  PLoS One       Date:  2019-02-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.